Team

Angel investor

Eench Lee

Eench has been an investor for 25. 10 years as a hedge fund manager culminating in being a founding partner at Cheyne Special Situation Funds, which has won numerous awards such as Eurohedge's best new european hedge fund award and Europe's best special situation fund.

15 years as an Angel investor in the fields of artificial intelligence, medical diagnostics medical research and fintech.

He is a hands on investor having seen award winning startups from inception to exit and is deeply passionate about medical advances, AI and finance.

He strongly believes that technology has a role to play in making the lives of patients better. And that every little step of medical advancement helps.

Chief Financial Officer

Johnatan Chia-Croft

Jonathan has over three decades experience in international capital markets.

From 1986 to 1992 he worked in convertible bond and warrant hedge arbitrage. He then moved into investment banking specialising in raising debt/equity hybrid capital for companies ranging from National Grid (UK) to New World China.

In 2000 he became involved in the fallout from the TMT Stockmarket crash and his focused moved to troubled companies. In 2003 he joined his long-term client to found a distressed debt specialist boutique.

In 2013 he launched Lonsin Global Credit Fund to invest in deep distressed and not well covered troubled companies.

Having studied Biochemical Engineering at University College London and spent his internship at Glaxo Pharmaceutical, Singapore Jonathan has joined Lion BioMed Limited to bring his capital markets experience to work on the BioMedical sector.

Chief Scientific Officer

Zorica Milosevic

Zorica completed her PhD in Molecular Biology, Cancer Research at the University of Belgrade. During her PhD she worked at the Faculty of Medicine in Ciudad Real, Spain, where she studied the effects of different drugs on cancer cell migration and invasion.

She has also worked as PostDoc at the Faculty of Medicine in Larissa, Greece where she studied in vivo cancer models (SCID, NSG mice). She has authored 14 scientific research papers published in high impact journals.

She has participated in more than 20 international conferences and workshops. Her PhD was awarded as the best PhD in Molecular Biology in 2014 in Serbia. She started her clinical research career in 2016 as a Medical Affairs Scientist at Syneos Health (Previously Inc Research - Inventiv Health).

Now she is Medical Manager in Syneos Health with 6 years of clinical research experience in Psychiatry and Oncology.